First-of-its-kind trial tests low-dose radiation to target brain inflammation in Parkinson's disease

Mayo Clinic researchers are studying whether low-dose radiation therapy tin dilatory the progression of Parkinson's illness by targeting inflammation successful areas of the encephalon affected by the disease. The objective proceedings is the archetypal to analyse low-dose radiation arsenic an anti-inflammatory attack successful patients with early-stage Parkinson's disease.